QuidelOrtho (QDEL) Capital Expenditures (2021 - 2026)

QuidelOrtho's Capital Expenditures history runs 6 years deep, the most recent figure standing at $34.0 million for Q1 2026.

• In Q1 2026, Capital Expenditures fell 39.5% year-over-year to $34.0 million; the TTM figure through Mar 2026 stood at $166.0 million (down 10.37% YoY), while the FY2025 annual figure was $188.2 million, down 3.54% from the prior year.
• Capital Expenditures came in at $34.0 million for Q1 2026 at QuidelOrtho, down from $45.3 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $66.1 million in Q1 2024 to a low of -$119.5 million in Q1 2023.
• A 5-year average of $35.3 million and a median of $46.5 million in 2024 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures surged 193.33% in 2023 and tumbled 39.5% in 2026, its largest moves.
• QuidelOrtho's Capital Expenditures stood at $22.5 million in 2022, then surged by 116.0% to $48.6 million in 2023, then retreated by 2.88% to $47.2 million in 2024, then retreated by 4.03% to $45.3 million in 2025, then decreased by 24.94% to $34.0 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $34.0 million, $45.3 million, and $49.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison